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Abstract
Background: Furunculosis, a disease caused with gram negative bacteria Aeromonas salmonicida
produces heavy losses in aquaculture. Vaccination against furunculosis reduces mortality of Atlantic
salmon but fails to eradicate infection. Factors that determine high individual variation of
vaccination efficiency remain unknown. We used gene expression analyses to search for the
correlates of vaccine protection against furunculosis in Atlantic salmon.
Results:  Naïve and vaccinated fish were challenged by co-habitance. Fish with symptoms of
furunculosis at the onset of mass mortality (LR - low resistance) and survivors (HR - high
resistance) were sampled. Hepatic gene expression was analyzed with microarray (SFA2.0 -
immunochip) and real-time qPCR. Comparison of LR and HR indicated changes associated with the
protection and results obtained with naïve fish were used to find and filter the vaccine-independent
responses. Genes involved in recruitment and migration of immune cells changed expression in
both directions with greater magnitude in LR. Induction of the regulators of immune responses was
either equal (NFkB) or greater (Jun) in LR. Expression levels of proteasome components and
extracellular proteases were higher in LR while protease inhibitors were up-regulated in HR.
Differences in chaperones and protein adaptors, scavengers of reactive oxygen species and genes
for proteins of iron metabolism suggested cellular and oxidative stress in LR. Reduced levels of free
iron and heme can be predicted in LR by gene expression profiles with no protection against
pathogen. The level of complement regulation was greater in HR, which showed up-regulation of
the components of membrane attack complex and the complement proteins that protect the host
against the auto-immune damages. HR fish was also characterized with up-regulation of genes for
proteins involved in the protection of extracellular matrix, lipid metabolism and clearance of
endogenous and exogenous toxic compounds. A number of genes with marked expression
difference between HR and LR can be considered as positive and negative correlates of vaccine
protection against furunculosis.
Conclusion: Efficiency of vaccination against furunculosis depends largely on the ability of host to
neutralize the negative impacts of immune responses combined with efficient clearance and
prevention of tissue damages.
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Background
Furunculosis caused by Aeromonas salmonicida spp salmon-
icida  is a bacterial disease affecting salmonid species,
including cultured and wild Atlantic salmon (Salmo salar
L.) (reviewed in [1,2]), salmonids and other fish species
[3-7]. Disease may have local and systemic, acute, suba-
cute and chronic forms with diverse symptoms ranging
from erratic swimming and slight darkening of skin, to
haemorrhage on the abdominal walls, viscera and heart
and ulcerative lesions [8]. Furunculosis is caused with
non-mobile, aerobic gram negative bacillus Aeromonas sal-
monicida. This is an opportunistic pathogen with diverse
strains that are characterized with different virulence.
Furunculosis may cause heavy losses in salmon aquacul-
ture due to mortality, decrease of growth rates, feed con-
version and fish quality. Large-scale vaccination made it
possible to reduce the incidence of disease and the use of
antibiotics [9]. At present commercial vaccines against
furunculosis are widely used and a number of experimen-
tal vaccines has been tried [10,11]. Vaccination decreases
mortality of Atlantic salmon but fails to prevent it com-
pletely. Difficulties in the development of neutralizing
vaccines are most likely accounted for by the high diver-
sity of A. salmonicida strains and mechanisms of patho-
genicity, which can be determined with various factors
including type three secretion system, A layer protein,
lipopolysaccharide, iron binding and outer membrane
proteins, peptidases and toxins of different nature
(reviewed in [2,11]). Knowledge of the virulence factors is
far from complete. The limited success of protection
against furunculosis is also related to high individual var-
iation of responses to vaccination in Atlantic salmon [12].
Vaccination against furunculosis provides pathogen spe-
cific protection [2,9,13]. This indicates an important role
of acquired immunity, which is however insufficient for
the complete prevention of mortality. Outcomes of dis-
ease may depend substantially on the events, which take
place after the recognition of pathogen. Activation of B
and T cells and the complement system results in mass
production of humoral factors that regulate recruitment
of immune cells in blood and infected tissues. This results
in the orchestration of anti-bacterial defense, including
effector mechanisms, neutralization and clearance of
exogenous and endogenous toxins, pathogens, damaged
cells and their components. Defensive responses form a
complex network, which may vary substantially among
individuals. There are many possible scenarios with suc-
cessful and deleterious outcomes. We used multiple gene
expression profiling to outline the mechanisms that deter-
mine success of vaccine protection against furunculosis in
Atlantic salmon and to search for the correlates of protec-
tion. Microarray analyses have been performed in fish vac-
cinated against different pathogens [14-17], however, to
our knowledge, this study is the first attempt to search for
the correlates of vaccine protection.
Results
Design of analyses
To search for the correlates of vaccine protection against
furunculosis, individual samples of fish that survived to
the end of challenge test with no apparent symptoms of
disease (high resistant, HR) were hybridized with pooled
samples of salmon with manifestation of furunculosis
(dark skin, lethargy, abnormal swimming behaviour and
small haemorrhages at the base of fins) [8] at the onset of
mass mortality (low resistance, LR). The same design of
hybridization was applied to unvaccinated fish and the
results were used to filter the vaccine-independent
changes of gene expression (Figure 1). Pathogen was
detected with qPCR in the liver and spleen of all analyzed
fish though the load was substantially lower in HR (Figure
2). Pilot microarray analyses of different tissues (heart,
spleen and liver of vaccinated fish) found greatest differ-
ences between HR and LR in the liver and this organ was
chosen for the continuation of studies. Real-time qPCR
results from all uninfected fish were used to form a cali-
brator sample in order to verify the microarray results and
to determine the direction of gene expression changes. We
report only genes that were associated with survival in vac-
cinated salmon.
Recruitment of immune cells
Up- and down-regulation of the immune cells markers
(Figure 3) could be evidence for the changes in the com-
position of leukocytes in the liver. Mammalian homolog
of CD37 (down-regulated) is expressed in mature B and T
cells and myeloid cells [18] while CD40 (induced), also
found in myeloid and B cells, is in addition expressed in
fibroblasts, endothelial cells and in the basal epithelial
cells [19]. Genes regulating cell motility also changed in
both directions (up-regulated and down-regulated) with
greater magnitude of responses seen in LR. Induction of
leukocyte cell-derived chemotaxin (LECT2), which
attracts neutrophils [20] was markedly greater in LR. Src
kinase-associated phosphoprotein 55-related protein
(SKAP2) was down-regulated. This protein is involved in
signalling activated by interactions between cells and
extracellular matrix (ECM) [21]. Microarray analyses
revealed lower expression levels in HR of a large group of
genes implicated in recruitment and motility of immune
cells (Figure 3B). Both annexin A1 (ANXA1) and annexin
A3 (ANXA3) showed noticeably lower levels in HR. The
anti-inflammatory activity of annexins (ANXAs) is attrib-
uted mainly to their ability to interfere with neutrophil
extravasation [22,23]. In mammals, ANXA1 is ubiqui-
tously expressed, while ANXA3 has more selective expres-
sion patterns and tissue distribution [24]. Migration of
cells is a highly regulated process controlled by cellular
interactions with ECM. HR showed lower expression lev-
els of integrin binding protein (ITGB1BP3/MIBP), which
mediates reduced laminin cell adhesion and inhibition of
matrix deposition [25]. Movement of cells involves theBMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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cytoskeleton. The 8-kDa dynein light chain (DLC8) is an
essential component of the dynein motor complex that
provides the driving force for microtubule-based trans-
port within cells [26]. A potential link between cytoskele-
ton dynamics and gene regulation is implied by the fact
that DLC8 binds to the inhibitor of the transcription fac-
tor NFkB preventing its translocation to the nucleus
[27,28]. Profilin and cofilin that are involved in the
restructuring of the actin filaments had lower expression
in HR (Figure 3B). Same difference was observed in
coronin 1-B, an actin-binding protein required for chem-
okine-mediated recruitment [29] and efficient cell protru-
sion and migration [30].
Signal transduction and regulation of gene expression, 
anti-bacterial effectors
Six genes known for their key roles in closely intervened
immune pathways were analyzed with both microarrays
and qPCR (Figure 4A). All were up-regulated in the
infected fish except for JunC in the HR group. The NFkB
complex regulates numerous genes involved in the
immune responses to bacteria [31]. Microarray analyses
suggested greater expression level of NF-kappaB-p105
(NFkB1) in HR but qPCR analyses did not confirm differ-
ence between the study groups. Given a 1000-fold
increase of NFkB1 in pathogen challenged fish in compar-
ison with uninfected controls, discrepancies could be
accounted for by the limited dynamic range of microarray
analyses. Real-time qPCR also did not detect differences
between the HR and LR in the expression of NF-kappaB
inhibitor alpha (NFKBIA) that retains NFkB in the cyto-
plasm. Structurally and functionally related c-Jun, JunB
and JunD together with the members of Fos and ATF/
CREB protein families make up the transcriptional regula-
tor AP-1, which is essential for the cooperative induction
of many cytokine genes [32]. AP-1 mediated regulation is
cell type specific, depends on the relative abundance of its
subunits and presence of other nuclear factors. For exam-
Design of gene expression analyses Figure 1
Design of gene expression analyses. Microarray comparison of HR (individual samples) with pooled LR outlined the gene 
expression changes associated with protection against A. salmonicida. Results obtained in naïve, unvaccinated fish indicated vac-
cine-independent protection and were used for the filtration of data obtained in vaccinated fish. Microarray analyses found 
genes with expression differences between LR and HR. The real-time qPCR analyses were conduced to verify the microarray 
results and to compare gene expression in the infected and uninfected fish. The numbers of differentially expressed genes are 
presented.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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ple, the pleiotropic transcription factor Yin Yang 1 (YY1),
whose higher levels were detected in HR by microarray,
plays important roles in immune cells [33,34] and co-
operates with AP-1 to regulate gene expression [35,36].
Microarray analyses (Figure 4B) showed differences
between HR and LR in genes that regulate gene expression
at different levels: signal transduction, promoter binding,
modification of chromosomes, maturation and mainte-
nance of mRNA. Several genes with known immune func-
tions showed higher expression levels in LR, including the
phosphotyrosine independent ligand for Lck SH2 or p62
that regulates activation of NFkB by TNFα [37]. General
transcriptional activity seemed repressed in HR in com-
parison to LR as judged by the profile of TATA-binding
protein associated factor 2N (TAF15), involved in the
transcription complex assembly and transcription initia-
tion by RNA polymerase II. Supportive of gene silencing
in HR was the up-regulation of the histone deacetylase 9
[38]. On the other side, polyadenylate-binding protein 4
(PABPC4) that was markedly over expressed in HR is
known for its ability to enhance the stability and transla-
tion of cytokine mRNAs [39].
Up-regulation of NFkB and AP-1 by pathogens and
cytokines induces mass production of immune mediators
and effector proteins. Expression differences in proteo-
some components and extracellular proteases (nephrosin,
matrix metalloproteinase 9 and tissue inhibitor of metal-
loproteinase) (Figure 5B) could be an evidence for the
higher level of protein degradation in LR. On the contrary,
improved resistance was associated with the activation of
protease inhibitors that protect tissues from damage.
Alpha-1-antiproteinase like protein (Antiprot1) was up-
regulated in HR while LR showed no difference when
compared to uninfected control (Figure 5A).
Cellular and oxidative stress, metabolism of iron
In addition to cytokines and pathogens, NFkB and Jun
proteins respond to various cell damaging factors, includ-
ing free radicals and other genotoxic agents that can cause
apoptosis, growth arrest, altered DNA repair or altered dif-
ferentiation. AP-1 contains cysteine motifs that regulate its
activity in response to oxidative stress [40]. NFkB can also
activate protection against oxidative and cellular stress by
providing anti-apoptotic and proliferation-promoting sig-
nals. A suite of chaperones and protein adaptors of differ-
ent types (heat shock proteins, 14-3-3 proteins, glucose
regulated proteins, DnaJ, cyclophilins) were expressed at
higher level in LR fish (Figure 5B) and this could be evi-
dence of cellular stress. Genes for proteins involved in reg-
ulation of redox status and protection against reactive
oxygen species (ROS) also showed differences between
the study groups. Five genes from this functional group
that had higher expression levels in HR are presented in
Figure 5B. In contrast, all genes involved in metabolism of
iron had higher expression levels in LR. Transferrin is an
extracellular transporter of iron and ferritin stores iron
inside cells. Protoheme IX farnesyltransferase is an
enzyme of heme biosynthesis while heme oxygenase
(HO) plays a key part in heme degradation. Real-time
qPCR showed induction of HO in all infected fish, con-
sistent with its potent cytoprotective and anti-inflamma-
tory functions [41], but the expression level was greater in
LR (Figure 4A). Hemopexin transports heme to the liver
for degradation and hepcidin regulates iron metabolism
at different levels. Both genes respond to bacterial patho-
gens in various fish species [42-44]. Differences between
LR and HR were also seen in regulators of cell cycle. Cyclin
D showed lower level in HR. This gene links external cues
with regulation of cell proliferation and directs entry to
G1 phase by phosphorylation of retinoblastoma protein
[45]. Our previous studies found marked activation of
cyclin D with toxicity and pathogens [46,47].
Complement
The complement is a complex system consisting of 3 path-
ways (classical, alternative and lectin), which helps to kill
and clear pathogens. The complement components are
present in plasma as inactive proteins and the biochemi-
cal cascade is triggered by recognition of pathogens. In
higher vertebrates, the complement pathways are acti-
vated in different ways. The C1Q component of C1 com-
plex of the classical pathways (CP) binds to antigen-
antibody complexes thus linking the innate and adaptive
arms of immunity. C-type mannose-binding lectin (MBL)
has the same role in lectin pathway (LP) but unlike C1Q
commonly does not require antibody. The alternative
pathway (AP) does not include specialized pathogen
Pathogen loads analysed by real-time qPCR in the liver and  spleen of vaccinated salmon Figure 2
Pathogen loads analysed by real-time qPCR in the 
liver and spleen of vaccinated salmon. Data are cycle 
threshold (Ct) ± SD. Differences between LR and HR are sig-
nificant (p < 0.001, ANOVA test, 8 fish per group).BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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binding proteins. To date, the sensor proteins of CP have
not been identified in salmonid fish. We included in anal-
yses the C1Q binding protein (C1QBP), which showed
greater expression in HR (Figure 6A). C1QBP is a ubiqui-
tously expressed protein found intracellularly, on the cell
surface, in plasma and the extracellular matrix. It interacts
with a host of proteins including the globular heads of
C1Q molecules, thus potentially modulating the numer-
ous C1Q-mediated functions [48]. The functional analog
of mammalian MBL is also unknown. Microarray results
suggested down-regulation of a C type MBL in HR. How-
ever qPCR analyses found a 1000-fold induction of MBL
in HR while there was no difference between LR and the
uninfected control. This disagreement can be accounted
for by the limited ability of cDNA microarrays to discrim-
inate between transcripts of structurally similar members
of multi-gene families. Blastx search of the MBL sequence
presented on the microarray (Genbank CA376643) found
three rainbow trout and nine Atlantic salmon proteins.
Despite considerable sequence divergence (similarity
ranged within 38-83%) the salmonid lectins contain
highly conserved domains (Figure 7) that, hypothetically,
Immune cell markers and genes involved in recruitment and migration of immune cells Figure 3
Immune cell markers and genes involved in recruitment and migration of immune cells. A: Real-time qPCR ver-
sus microarray analyses. Results demonstrated concordance in direction of change between the two techniques supporting dif-
ferential regulation of the gene subset. Data for qPCR are ΔΔCt ± SE of 10 HR and 10 LR versus 8 fish in the unchallenged 
control and data for microarray are mean log2-ER ± SE of 6 HR fish hybridized to a pooled sample of 10 LR fish. Differences 
between HR and LR determined with microarrays and qPCR are shown. Different capital letters (A, B) denote a difference 
between challenged fish (HR and LR) while small letters (a, b) denote a difference between challenged and control fish 
(ANOVA, P < 0.05). LECT2 - leukocyte cell-derived chemotaxin 2, SKAP2 - Src kinase-associated phosphoprotein. B: Microar-
ray results, examples of differentially expressed genes with significant differences between vaccinated and unvaccinated fish (t-
test, n = 6 and 5, p < 0.05). Results for unvaccinated fish are not shown, data are log2-ER ± SE.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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may cross-hybridize. The actual number of salmonid
MBL-like proteins and their relation to the complement
system remain unknown. The genes for other serum com-
ponents of the complement had greater expression levels
in HR. These are serine proteases of lectin (MASP) and
alternative pathways (factors B), C3, the convergence
point of all complement pathways, C5 and C9, the parts
of membrane attack complex. Factor H is a regulator of
the alternative pathway while vitronectin (VTN) protects
tissues against damages caused by the terminal membrane
attack complex. The cell surface receptors of C1Q and C
type lectin had higher expression in LR (Figure 6B). We
show these genes since theoretically, they may interact
with the complement system. However, their roles in sal-
monid fish are unknown and await exploration.
Clearance and reparation
HR was characterized with markedly higher expression
levels of genes that protect tissues from damages, neutral-
ize and remove toxic compounds and products of cell deg-
radation (Figure 8A). Fibronectin (FN1) is an acute phase
protein required for protection and reparation of ECM
[49]. CYP3A7 can metabolise a number of endogenous
and exogenous compounds [50,51] while liver bile salt
export pump (ABCB4) mediates transmembrane move-
ment of phosphatidylcholine and cholesterol from liver
hepatocytes into bile [52]. MA analyses found a panel of
genes involved in clearance, detoxification and reparation
of tissues with higher expression levels in HR (Figure 8B).
Removal of cholesterol seems to have high importance as
evidenced by the profile of ATP-binding cassette trans-
porter 1 (ABCA1), a cholesterol efflux pump in the cellu-
lar lipid removal pathway [53]. The intermediary
metabolic enzyme alanine-glyoxylate aminotransferase
(AGXT) is involved in the detoxification of glyoxylate, a
product of amino acid metabolism and purine degrada-
tion in Atlantic salmon [54]. Previously we reported up-
regulation of this gene in the liver of trout exposed to tox-
icity [46]. A number of genes with higher expression in
HR have roles in the transport and modification of lipids.
The exact metabolic function of the up-regulated trans-
porter fatty acid-binding protein-3 (FABP3) in Atlantic
salmon's liver remains unclear [55]. Diacylglycerol kinase
delta 2 (DGKD) is involved in the conversion of diacylg-
lycerol to produce phosphatidic acid. One more lipid-
binding protein, beta-2 glycoprotein I, also known as
apolipoprotein H is a precursor of anti-bacterial peptides
[56]. Differences between the study groups were observed
in several genes encoding growth factors. Melanoma-
derived growth regulatory protein (MIA) (down-regulated
in HR) mediates detachment of cells from ECM structures
enhancing their migratory potential [57]. The up-regu-
lated fibroblast growth factor-20 is a potent mitogen that
induces DNA synthesis and cell proliferation [58].
Discussion
Vaccines development is targeted at the complete neutral-
ization of pathogens via binding to antibodies or TCR.
However to date this aim has not been achieved for many
diseases of Atlantic salmon including furunculosis. Vacci-
Signal transducers and regulators of gene expression Figure 4
Signal transducers and regulators of gene expression. The figure shows expression changes indicative of recruitment 
and migration of immune cells. A. Real-time qPCR versus microarray analyses. Data for qPCR are ΔΔCt ± SE of 10 HR and 10 
LR versus 8 fish in the unchallenged control and data for microarray are mean log2-ER ± SE of 6 HR fish hybridized to a pooled 
sample of 10 LR fish. Differences between HR and LR determined with microarrays and qPCR are shown. Different capital let-
ters (A, B) denote a difference between challenged fish (HR and LR) while small letters (a, b) denote a difference between chal-
lenged and control fish (ANOVA, P < 0.05). NFKB1 - nuclear factor NF-kappa-B p105 subunit, NFKBIA - NF-kappa-B inhibitor 
alpha, CREBBP - CREB-binding protein, YY1 - YY1 transcription factor. B. Microarray results, examples of differentially 
expressed genes with significant differences between vaccinated and unvaccinated fish (t-test, n = 6 and 5, p < 0.05). Results for 
unvaccinated fish are not shown, data are log2-ER ± SE.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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nation reduces mortality but fails to provide a complete
protection as confirmed in this study. Vaccinated HR fish
that survived to the end of challenge test still showed rel-
atively high levels of infection in the liver and spleen and
induction of genes known for strong responses to bacte-
rial pathogens. For example NFkB was induced 1000-fold
with respect to the uninfected control. Markedly lower
pathogen loads in HR suggested that survival of the vacci-
nated salmon was most likely determined with the ability
to suppress and clear bacteria. Comparisons of gene
expression within the groups of vaccinated and naïve fish
found large scale differences between HR and LR. It is
noteworthy to mention that analyses with vaccinated fish
did not find significant role of genes involved in adaptive
Anti-bacterial effectors, markers of cellular and oxidative stress Figure 5
Anti-bacterial effectors, markers of cellular and oxidative stress. A. Real-time qPCR versus microarray analyses. Data 
for qPCR are ΔΔCt ± SE of 10 HR and 10 LR versus 8 fish in the unchallenged control and data for microarray are mean log2-
ER ± SE of 6 HR fish hybridized to a pooled sample of 10 LR fish. Differences between HR and LR determined with microarrays 
and qPCR are shown. Different capital letters (A, B) denote a difference between challenged fish (HR and LR) while small let-
ters (a, b) denote a difference between challenged and control fish (ANOVA, P < 0.05). HO - heme oxygenase; GPX3 - plasma 
glutathione peroxidase; GPX2 - gastrointestinal glutathione peroxidase; ALOX5AP arachidonate 5-lipoxygenase-activating pro-
tein; CCND2 - G1/S-specific cyclin D2; Antiprot1 - alpha-1-antiproteinase-like protein. B. Microarray results, examples of dif-
ferentially expressed genes with significant differences between vaccinated and unvaccinated fish (t-test, n = 6 and 5, p < 0.05). 
Results for unvaccinated fish are not shown, data are log2-ER ± SE.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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Genes involved in the complement cascade Figure 6
Genes involved in the complement cascade. A. Real-time qPCR versus microarray analyses. Data for qPCR are ΔΔCt ± 
SE of 10 HR and 10 LR versus 8 fish in the unchallenged control and data for microarray are mean log2-ER ± SE of 6 HR fish 
hybridized to a pooled sample of 10 LR fish. Differences between HR and LR determined with microarrays and qPCR are 
shown. Different capital letters (A, B) denote a difference between challenged fish (HR and LR) while small letters (a, b) denote 
a difference between challenged and control fish (ANOVA, P < 0.05). C1QBP - complement component 1, Q subcomponent 
binding protein; MBL - C-type mannose-binding lectin; MASP - mannan-binding lectin serine protease, C5 - complement com-
ponent C5, C4BPA - complement component 4 binding protein, alpha, VTN - vitronectin. B. Microarray results, examples of 
differentially expressed genes with significant differences between vaccinated and unvaccinated fish (t-test, n = 6 and 5, p < 
0.05). Results for unvaccinated fish are not shown, data are log2-ER ± SE.
Alignment of rainbow trout and Atlantic salmon lectins Figure 7
Alignment of rainbow trout and Atlantic salmon lectins. Sequence information includes the Genbank accession 
number; species is indicated as Omy for Oncorhynchus mykiss and Ssa for Salmo salar. Omy185132516 is encoded by the tran-
script spotted on the microarray. The sequences were aligned with ClustalX. D. Alignment of the predicted complement com-
ponent 1, Q subcomponent binding protein (C1QBP) from three fish species with the human ortholog; species is indicated as 
Omy for Oncorhynchus mykiss, Ssa for Salmo salar, Dr for Danio rerio and Hs stands for Homo sapiens. The sequences are availa-
ble at the accession numbers: human DQ891331, salmon paralog 1, salmon paralog 2, trout paralog 1 and trout paralog 2. The 
sequences were aligned with ClustalX.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
Page 9 of 15
(page number not for citation purposes)
immune responses. This was in contrast with our studies
of salmon challenges with virus (ISAV), which showed
clear dependence between resistance evaluated by time of
survival and activation of adaptive immunity [59]. Rapid
stimulation of Igs was also seen in salmon challenged
with the parasite, salmon louse [60]. Apparently, patho-
gen did not stimulate further activation of adaptive
immunity in the vaccinated fish. Therefore one may
assume that vaccine-dependent protection of salmon
infected with A. salmonicida was determined mainly with
the events that take place after recognition of the patho-
gen. Given high complexity and diversity of this network
and limited level of knowledge, multiple gene expression
profiling provides an efficient approach to search for the
protective mechanisms.
The gene expression analyses were designed with focus on
the mechanisms of vaccine-dependent protection against
furunculosis. Genes with greater expression changes in HR
can be regarded as candidate markers of protection while
opposite regulation may indicate either pathology or
unsuccessful defense. Overall, expression changes that can
be interpreted as active anti-bacterial responses tended to
be greater in LR. We produced an indirect evidence for
larger regulation of immune cells recruitment in LR. More
detailed study of the immune cells populations is compli-
cated with shortage of cell-specific markers for salmon.
Interaction of recruited and resident cells with pathogen
components and cytokines activates signal transducers
and other regulators of gene expression. We found
increase of several genes known for their key roles in
responses to pathogens and the magnitude was either
greater in LR or equal in LR and HR (NFkB).
A panel of genes for proteins involved in metabolism of
iron had higher expression in LR. These regulations indi-
cate the need to reduce the levels of free inorganic iron
and heme. HO was activated in all infected fish but the
magnitude was greater in LR. HO is the rate-controlling
enzyme of the degradation of heme into iron, carbon
monoxide, and biliverdin, which is subsequently con-
verted to antioxidant bilirubin [61]. Extracellular iron
ions bind to transferrin, which delivers it into cells.
Within cells iron is stored as complex with ferritin. Dam-
age of erythrocytes is one of the symptoms of furunculo-
sis. Heme and iron catalyze production of free radicals
through Fenton's reaction thus increasing risk of oxidative
stress. Shortage of iron may suppress proliferation of
pathogenic bacteria and therefore sequestration of bioa-
vailable iron and heme is regarded as anti-bacterial
defense. In case of furunculosis this strategy is obviously
unsuccessful.
The complement system was the only group of immune
genes that showed strong association with survival and
several genes presented in Figure 8A can be considered as
Genes involved in tissue protection, clearance and reparation Figure 8
Genes involved in tissue protection, clearance and reparation. A. Real-time qPCR versus microarray analyses. Data 
for qPCR are ΔΔCt ± SE of 10 HR and 10 LR versus 8 fish in the unchallenged control and data for microarray are mean log-ER 
± SE of 6 HR fish hybridized to a pooled sample of 10 LR fish. Differences between HR and LR determined with microarrays 
and qPCR are shown. Different capital letters (A, B) denote a difference between challenged fish (HR and LR) while small let-
ters (a, b) denote a difference between challenged and control fish (ANOVA, P < 0.05). FN1 - fibronectin, ABCB4 - liver bile 
salt export pump. B. Microarray results, examples of differentially expressed genes with significant differences between vacci-
nated and unvaccinated fish (t-test, n = 6 and 5, p < 0.05). Results for unvaccinated fish are not shown, data are log2-ER ± SE.BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
Page 10 of 15
(page number not for citation purposes)
candidate markers of vaccine protection against furuncu-
losis. The complement system is the major link between
the effector anti-bacterial mechanisms of adaptive and
innate arms of immunity. The role of complement in anti-
body mediated defense against A. salmonicida was demon-
strated in rainbow trout. Combination of specific IgM and
complement accelerated ingestion of bacteria and inges-
tion-activated respiratory burst in phagocytes [62]. The
complement pathways converge at the level of C3 conver-
tase, which initiates the anti-bacterial effector mecha-
nisms. C3 and the downstream genes, the parts of
membrane attack complex had higher expression levels in
HR, especially C5. Mobilization of the effector comple-
ment mechanisms correlated with survival, however it
remained unknown, which of the complement pathways
was responsible for these changes. Increase of C1QBP, the
negative regulator of CP was greater in LR. This could be
regarded as indirect evidence for higher activity of CP in
HR, however, the expression difference between the study
groups was relatively small. Furthermore, it remains
unknown if CP provides the only or the major connection
between the complement system and acquired immunity
in salmonid fish. Homolog to mammalian C1Q was
found in lampreys, primitive vertebrates that lack adap-
tive immunity [63]. The link between the classical path-
way and antibodies appeared in the course of vertebrate
evolution but the timing of this event remains undefined.
C1Q is the member of a large multi-gene family with
diverse functions [64]. Analysis of non-redundant Atlantic
salmon mRNA sequences with blastx revealed 17 distinct
C1Q related transcripts. To our knowledge, the antigen-
antibody complex binding protein of salmonid CP has
not been identified so far. In theory, interaction between
the fish complement and acquired immunity molecules
can be mediated by MP. MBL interacts with immunoglob-
ulins in mammals [65] despite the principal role of CP in
recognition of antibody antigen complexes. The qPCR
analyses showed dramatic up-regulation of MBL in HR.
Given the lack of changes in LR, this gene is one of the
most promising markers of the vaccine-dependent protec-
tion. However taking into account the presence of multi-
ple lectins with unknown roles in Atlantic salmon,
induction of MBL does not necessarily mean activation of
MP. Furthermore, MASP showed no increase in HR in
comparison with uninfected control. Expression profiles
of the complement factors Bf and B/C2-B suggested higher
activity of AP in HR, however, differences between HR and
LR were minor. Diversity of putative sensor proteins in
salmonid fish and limited knowledge on their functions
impede interpretation of the gene expression data.
Importantly, HR showed greater expression of factor H,
the negative regulator of AP, and vitronectin (VTN), a pro-
tein that protects host tissues from the complement dam-
ages. Similarly, the transcript encoding alpha
antiproteinase-like protein was up-regulated in HR rela-
tive to LR. Vaccine-dependent resistance to furunculosis
was clearly associated with the abilities to prevent and
repair damages from pathogen and immune responses
and to neutralize and clear toxic compounds of endog-
enous and exogenous origin. The genes shown in Figure 8
can be divided in three functional groups - tissue repara-
tion, clearance and xenobiotic metabolism - each repre-
sented with a gene whose markedly greater up-regulation
in HR was confirmed with two methods. Elevated levels of
fibronectin can be beneficial since FN1 is involved in rep-
aration of tissues at the wound contraction stage of
wound healing [66]. Due to its opsonic properties,
fibronectin takes part in the removal of unwanted sub-
stances in the liver by phagocytic Kupffer cells [67].
CYP3A4 metabolizes a strikingly large number of xenobi-
otics including bacterial toxins and more than half of
modern prescription drugs. This gene is down-regulated
in inflammatory conditions by a range of cytokines and
NFkB [68,69]. Hence individuals with strong innate
immune responses may have a higher risk of bacterial
intoxication. The role of ABCB4 in bacterial diseases has
not been reported so far. One may speculate that the
transporter protein that directs phospholipids from liver
to bile can be important for clearance of remains of killed
cells and bacteria. Transcriptomic comparison of salmon
with high and low resistance to pathogen indicated piv-
otal importance of processes that deserve more attention
in studies of fish diseases.
Conclusion
Gene expression analyses revealed significant differences
between vaccinated fish with high and low resistance to
furunculosis. We did not find strong association between
survival and most anti-bacterial responses though HR
showed higher expression levels of several complement
components. Results suggest that outcomes of vaccination
depend largely on the ability of host to prevent the nega-
tive impacts of immune responses and to repair damages.
This can be illustrated with the inductions of protease
inhibitors, negative regulators of complement, genes
involved in metabolism of lipids and xenobiotics and
growth factors. Studies outlined a number of genes with
positive and negative correlation with protection.
Methods
Challenge trials
The unvaccinated Atlantic salmon was from 279 full sib
families (the offspring of 140 sires and 279 dams) while
the vaccinated fish were a random sample of fish from
150 of the 279 families (the offspring of 87 sires and 150
dams). The families were produced by Salmo Breed AS in
November 2006 and were reared in separate trays and
tanks at Nofima Marin Sunndalsøra to a body size suita-
ble for individually tagging with pit-tags in July (30 fish/
family) and September (15 fish/family) 2007. The 30
fish/family were vaccinated intraperitoneally with a sixBMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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component oil adjuvanted vaccine from PHARMAQ on 2
to 4 October 2007.
The pathogen challenge trials were approved by The
National Animal Research Authority http://www.fdu.no
according to the 'European Convention for the Protection
of Vertebrate Animals used for Experimental and other
Scientific Purposes' (EST 123).
Two groups of fish were infected with furunculosis at
VESO Vikan, Norway in two separate tanks; the unvacci-
nated fish on 2 October 2007 at an average body weight
of 30 g and the vaccinated fish on 22 November 2007 at
an average body weight of 46 g. Infection was performed
by cohabitation of 300 salmon (shedders) injected intra-
peritoneally with a virulent strain of A. salmonicida O2.
The trial with unvaccinated fish was terminated after 20
days when cumulative mortality reached 76% while the
trial with vaccinated fish, including 100 unvaccinated fish
from the same families as controls was terminated after 60
days when cumulative mortality was 39% (vaccinated)
and 72% (controls). In both trials liver, spleen and heart
were sampled from 10 fish with symptoms of disease
(darker colour, unusual swimming behaviour) at 10%
cumulative mortality (14 and 22 days after challenge of
respectively vaccinated and unvaccinated fish) and 10 fish
at the end of trials. These groups were designated respec-
tively as low resistant (LR) and high resistant (HR). Tissue
samples were immediately dissected in 6 mm3  pieces
using RNase-free procedures and preserved in >1:10 v/v of
RNALater (Ambion, Austin, TX, USA) at 4°C overnight
following storage at -20°C. Presence of A. salmonicida
infection was confirmed on a selection of fish at each stage
by inoculating tryptic soy agar with swabs from posterior
kidney and incubating at room temperature overnight. In
addition, levels of bacteria in liver and spleen from both
stages were assessed by PCR (see below).
Detection of pathogen
DNA was extracted from the liver and spleen of vaccinated
fish using the Qiagen DNeasy Blood and Tissue kit
(Hilden, Germany) according to manufacturer's instruc-
tions. Equal amounts of isolated DNA (1.2 μg) were used
as templates in 12 μl qPCR reaction volumes. DNA frag-
ment (accession number X64214), reported to be highly
specific for Aeromonas salmonicida (Hiney et al, 1992) was
used to design primers. The cycling conditions were 95°C
for 5 min (preincubation), 95°C for 5 sec, 60°C for 15
sec, 72°C for 15 sec (amplification); 95°C for 5 sec, 65°C
for 1 min (melting curve); 55 cycles were performed.
Microarray analyses
The salmonid fish microarray (SFA2, immunochip)
includes 1800 unique clones printed each in six spot rep-
licates. The complete composition of platform and
sequences of genes are provided in submission to NCBI
GEO Omnibus (GPL6154). Total RNA was extracted with
TriZOL (Invitrogen) and purified with Pure Link (Invitro-
gen) according to the manufacturer's instructions. RNA
was quantified using a NanoDrop 1000 spectrophotome-
ter (Thermo Fisher Scientific, Wilmington, USA) and RNA
integrity assessed using Bioanalyzer (Agilent 2100 Bioan-
alyzer, Agilent Technologies, Waldbronn, Germany) all
samples giving RIN >8 and high purity without DNA con-
tamination. The liver was chosen based on the results of
pilot hybridizations with different tissues. Individual HR
samples (6 vaccinated fish and 5 naïve fish) were hybrid-
ized to pooled LR samples (equal contribution from 6
fish) from the same groups. RNA (20 μg in each sample)
was labelled with respectively Cy5-dUTP and Cy3-dUTP
(Amersham Pharmacia). The fluorescent dyes were incor-
porated in cDNA using the SuperScript™ Indirect cDNA
Labelling System (Invitrogen, CA, USA). The cDNA syn-
thesis was performed at 46°C for 3 hours in a 20 μl reac-
tion volume, following RNA degradation with 0.2 M
NaOH at 37°C for 15 min and alkaline neutralization
with 0.6 M Hepes. Labelled cDNA was purified with
Microcon YM30 (Millipore). The slides were pretreated
with 1% BSA fraction V, 5× SSC, 0.1% SDS (30 min at
50°C) and washed with 2 × SSC (3 min) and 0.2 × SSC (3
min) and hybridized overnight at 60°C in a cocktail con-
taining 1.3 × Denhardt's, 3 × SSC 0.3% SDS, 0.67 μg/μl
polyadenylate and 1.4 μg/μl yeast tRNA. After hybridiza-
tion slides were washed at room temperature in 0.5 × SSC
and 0.1% SDS (15 min), 0.5 × SSC and 0.01% SDS (15
min), and twice in 0.06 × SSC (2 and 1 min, respectively).
Scanning was performed with GenePix4100A and images
were processed with GenePix 6.0 (Molecular Devices).
The spots were filtered by criterion (I-B)/(SI+SB)   0.6,
where I and B are the mean signal and background inten-
sities and SI, SB are the standard deviations. Low quality
spots were excluded from analysis and genes presented
with less than three high quality spots on a slide were dis-
carded. After subtraction of median background from
median signal intensities, the expression ratios (ER) were
calculated. Lowess normalization was performed first for
the whole slide and next for twelve rows and four columns
per slide. The differentially expressed genes were selected
using a two step procedure. First, technical accuracy was
assessed by difference of log2-ER from zero in six spot rep-
licates (Student's t-test, p < 0.01). The mean values were
calculated and a single value per fish was used in subse-
quent analyses. Second, the genes with technically signif-
icant changes in at least half of vaccinated and naïve fish
were selected and difference between these groups was
assessed by biological replicates (t-test, p < 0.05). At total,
13 microarrays were used, one for the heart and spleen
and 11 for the liver. Complete microarray results are pro-
vided in Additional file 1 and the data were submitted to
NCBI GEO Omnibus (GSE18120).BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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Quantitative real-time RT-PCR
Twenty five genes were selected for qPCR analyses taking
into account their functional roles and the results of
microarray analyses (Table 1). All genes were analyzed in
vaccinated (experimental) and uninfected (control) fish.
Total RNA was extracted and quality assessed as described
in the section above. The cDNA synthesis was performed
on 0.5 μg of DNAse-treated total RNA (according to man-
ufacturer's protocol for routine DNAse treatment, Turbo
DNA-free™ (Ambion, Austin, TX, USA) using TaqMan®
Table 1: Real-time qPCR analyses.
Genbank accessions, target Primer sequence from 5' to 3' PCR efficiency
CA366296, Src kinase associated phosphoprotein F GAGGTGCTCCCAGAGGATGACA
R CAGTCCCACAAGCCCTGGTAGT
2.0
CA349943, C-type mannose-binding lectin F TCCATTGCACTGGGCGATGC
R CACTGCTTCCACCTGAGCCTCA
1.667
CA361395, Leukocyte antigen CD37 F TGCTGAGACAAGCTTCTTCATGCC
R CGACATCGTAGCACTTCCACCAAT
1.696
CA364370, CD40 F CTGTAAACTGCACCCATACTGCGAC
R ATGGGCTGAGGCTTGTCTTGTTC
1.716
CU068239, Leukocyte cell-derived chemotaxin 2 F CTGTGTTGTCAGAGTGCGAGATGGT
R TACACACAATGTCCAGGCCCTGA
1.899
CA369467, 5-lipoxygenase activating protein F TCTGAGTCATGCTGTCCGTAGTGGT
R CCTCCCTCTCTACCTTCGTTGCAAA
1.751
CA366162, Alpha-1-antiproteinase-like protein F CCACAAGGCTGTGCTGAGCGTA
R TGAGCATGATGGTGTCTGGGAGAG
1.702
CA366315, YY1 transcription factor F AAAGAAGACGACGCGCCCAG
R GGTGTGGAGATGCTTCCTCATCG
1.893
CF752495, Jun B F CATCAGAAGTCGGCTCGCTGAA
R GGTGTCGGTGTGGTAGTGATGACA
1.743
CA341859, NFkB1 F CAGCGTCCTACCAGGCTAAAGAGAT
R GCTGTTCGATCCATCCGCACTAT
1.685
CA343143, NFkB inhibitor F TGGTAACCTTGTGAAGGAGCTGGA
R GCTCAGCATGTTCTGTGGCTTCAT
2.00
CA361415, Jun C F CAGCATGACACTGAACCTGGCTGA
R GCAAGTTTGAGGAGCTGCACATCC
2.00
CA345853, Plasma glutathione peroxidase precursor F CCTTCCAGTACCTGGAGTTGAATGC
R CTCATGATTGTCTCCTGGCTCCTGT
1.904
CF753103, Glutathione peroxidase-gastrointestinal F TGTACCTCAAGGAGAAGCTGCCGT
R ATTAAGGCCATGGGATCGTCGC
2.00
CA363120, Heme oxygenase F TGGGTCTGACCTGGGTCCTCTCAT
R GAGGGTGGTTTCAGCGTTGAGC
1.664
CA368533, Vitronectin F AAGCCCTTCGACGCCTTCCT
R CCTCTGATGCCCCACTTGTCGTAG
2.00
CA382259, Complement component 4 binding protein F TGGTGGAGTATCAGTGTGACAGGCA
R GGTGGATTTGGCTCAAACTGTCCT
2.00
CA364804, Complement component 5-2 F AGAACTCTTCCGAGTTGGCATGGT
R AGTGATGCTGGGATCCATCTCTGA
1.952
CA366393, Mannan-binding lectin serine peptidase F TCAGGTGCTGACGGAGAGGTCA
R GCACTCTGAATCCCTCTGGTAGGAG
1.971
CA387557, Complement component 1Q binding F CGGTCTCTCTGGATGATGAGCCATA
R CCACATCCACACGACACAGGAGTA
2.00
CA376069, Cytochrome P450 3A27 F CCAACCTGCTGAACGGAATGAA
R AGAACTCCTTCACTTCGATGGCCT
2.00
CA378743, Fibronectin F GCATGTCTGAGACGGGCTTCAA
R AGTCACATCGGAAGTGTCCACTGC
2.00
CA384134, G1/S-specific cyclin D2 F CATCAGACCACAGGAGTTGCTGGA
R AAGTCATTTGGAGTGACAGCCGC
2.00
CA363965, Liver bile salt export pump F TACGACACCAACGTAGGTTCCCAGG
R GGATCTTAGGGTCGCGGATGATC
1.686
CA385588, CREB binding protein F CTCCAGCCCAGGCCAACTCC
R GGCCAGGCAGGTGAGCTCCT
2.00
X64214, A. salmonicida genomic DNA fragment F GTTTACCACGTAATCTGAATTGTTCTTTTC
R ATTGCTTATCGAGGCAGCCAAC
1.890
AJ427629, 18S rRNA F GCCCTATCAACTTTCGATGGTAC
R TTTGGATGTGGTAGCCGTTTCTC
2.00BMC Genomics 2009, 10:503 http://www.biomedcentral.com/1471-2164/10/503
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Gold Reverse Transcription kit (Applied Biosystems, CA,
USA) and oligo dT primers, according to manufacturer's
protocol. PCR primers were designed using Vector NTI
(Invitrogen) and synthesized by Invitrogen. The amplicon
lengths set to be between 50 and 200 bases were checked
on 1.5% agarose gel. PCR efficiency was calculated from
tenfold serial dilutions of cDNA for each primer pair in
triplicates. Real-time PCR assays were conducted using 2×
SYBR® Green Master Mix (Roche) in an optimised 12 μl
reaction, using 1:10 diluted cDNA, primer concentrations
of 0.4-0.6 μM each. PCR was performed in duplicates in
96-well optical plates on Light Cycler 480 (Roche) under
the following conditions: 95°C for 5 min (preincuba-
tion), 95°C for 5 sec, 60°C for 15 sec, 72°C for 15 sec
(amplification), 95°C for 5 sec, 65°C for 1 min (melting
curve). 45 cycles were performed. Relative expression of
mRNA was evaluated by ΔΔCT. Three commonly used
candidate reference genes (18s rRNA, eukaryotic transla-
tion initiation factor 3 subunit 6 and elongation factor EF-
1a) were tested and 18s rRNA was selected as the reference
gene for all samples by the stability criteria. Dependence
of gene expression on infection, vaccination and resist-
ance was analyzed with ANOVA (p < 0.05).
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